159
Participants
Start Date
November 30, 2009
Primary Completion Date
May 31, 2010
Study Completion Date
May 31, 2010
REGN475
Single Subcutaneous injection dose level 1
REGN475
Single subcutaneous injection dose level 2
Placebo Injection
Placebo Subcutaneous injection
Regeneron Investigational Site, Birmingham
Regeneron Investigational Site, Mobile
Regeneron Investigational Site, Peoria
Regeneron Investigational Site, Anaheim
Regeneron Investigational Site, Beverly Hills
Regeneron Investigational Site, National City
Regeneron Investigational Site, Santa Ana
Regeneron Investigational Site, Milford
Regeneron Investigational Site, Stamford
Regeneron Investigational Site, Clearwater
Regeneron Investigational Site, Hallandale
Regeneron Investigational Site, St. Petersburg
Regeneron Investigational Site, Tampa
Regeneron Investigational Site, West Palm Beach
Regeneron Investigational Site, Atlanta
Regeneron Investigational Site, Sandy Springs
Regeneron Investigational Site, Overland Park
Regeneron Investigational Site, Rockville
Regeneron Investigational Site, Kansas City
Regeneron Investigational Site, Albuquerque
Regeneron Investigational Site, Raleigh
Regeneron Investigational Site, Cincinnati
Regeneron Investigational Site, Duncansville
Regeneron Investigational Site, Tyrone
Regeneron Investigational Site, Warwick
Regeneron Investigational Site, Greer
Regeneron Investigational Site, Memphis
Regeneron Investigational Site, El Paso
Regeneron Investigational Site, San Antonio
Regeneron Invesitgational Site, West Jordan
Collaborators (1)
Sanofi
INDUSTRY
Regeneron Pharmaceuticals
INDUSTRY